Research analyzes over 50,000 food products, highlighting the dominance of ultra-processed options in grocery stores and its implications for public health.
Trastuzumab duocarmazine by Byondis for Gastric Cancer: Likelihood of Approval
Trastuzumab duocarmazine is under clinical development by Byondis and currently in Phase I for Gastric Cancer.